Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted
STN#: 125419
Proper Name: Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted
Tradename: N/A
Manufacturer: ID Biomedical Corporation of Quebec
Indication
- For active immunization for the prevention of disease caused by the influenza A virus H5N1 subtype contained in the vaccine. Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted is approved for use in persons (6 months and older) at increased risk of exposure to the influenza A virus H5N1 subtype contained in the vaccine.
Product Information
Supporting Documents
- Statistical-Clinical Review - Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted
- Clinical Review - Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted
- Statistical-Clinical Review - Addendum - Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted
- Approval History, Letters, Reviews, and Related Documents - Q-Pan
- Supporting Documents older than three years - Q-Pan